Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
pyrithione zinc + disodium undecylenamido MEA-sulfosuccinate
- Development stage
- Unknown
- Lead developer
- Permamed
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Squa-med is a topical medicated shampoo developed by Permamed for the treatment of various scalp conditions, including seborrheic dermatitis, dandruff, scalp psoriasis, and pityriasis versicolor. It is formulated as a combination of two active ingredients: pyrithione zinc, which acts as a fungistatic and bacteriostatic agent to inhibit microbial growth and normalize skin cell turnover, and disodium undecylenamido MEA-sulfosuccinate, an anionic surfactant that prevents excessive greasing of the hair and provides mild antimycotic and antiseborrheic effects. Together, these components work synergistically to reduce scaling, soothe itching, and restore the natural balance of the scalp.
- Brand names
- Squa-medSqua-med Medizinal Shampoo
- Other names
- pyrithione zinc + disodium undecylenamido-MEA-sulfosuccinatepyrithionum zincum + dinatrii undecylenamidi monoethanolamidi sulfosuccinas
02
Targets
KCNQ1 (Potassium voltage-gated channel subfamily KQT member 1)
Beyond the preview
Go deeper on pyrithione zinc + disodium undecylenamido MEA-sulfosuccinate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on pyrithione zinc + disodium undecylenamido MEA-sulfosuccinate.